Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Gene Expression Market 

5.1. COVID-19 Landscape: Gene Expression Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Gene Expression Market, By Process

8.1. Gene Expression Market Revenue and Volume Forecast, by Process, 2023-2032

8.1.1. Sample collection

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Purification

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Data analysis and interpretation

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. PCR analysis

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

8.1.5. cDNA synthesis

8.1.5.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Gene Expression Market, By Product

9.1. Gene Expression Market Revenue and Volume Forecast, by Product, 2023-2032

9.1.1. Instruments

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Reagents and Consumables

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

9.1.3. Services

9.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Gene Expression Market, By Capacity 

10.1. Gene Expression Market Revenue and Volume Forecast, by Capacity, 2023-2032

10.1.1. Low- to Mid-Plex

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. High-Plex

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Gene Expression Market, By End User 

11.1. Gene Expression Market Revenue and Volume Forecast, by End User, 2023-2032

11.1.1. Pharmaceutical and biotechnology companies

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. Diagnostic Laboratories

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

11.1.3. Academic Research Centers

11.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global Gene Expression Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.1.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.1.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.1.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.1.5.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.1.5.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.1.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.1.6.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.1.6.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.1.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.2.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.2.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.2.5.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.5.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.2.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.2.6.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.6.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.2.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.2.7.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.7.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.2.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.2.8.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.8.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.2.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.3.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.3.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.3.5.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.5.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.3.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.3.6.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.6.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.3.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.3.7.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.7.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.3.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.3.8.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.8.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.3.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.4.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.4.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.4.5.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.5.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.4.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.4.6.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.6.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.4.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.4.7.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.7.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.4.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.4.8.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.8.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.4.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.5.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.5.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.5.5.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.5.5.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.5.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Process (2020-2032)

12.5.6.2. Market Revenue and Volume Forecast, by Product (2020-2032)

12.5.6.3. Market Revenue and Volume Forecast, by Capacity (2020-2032)

12.5.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

Chapter 13. Company Profiles

13.1. QIAGEN

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Quest Diagnostics, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. F. Hoffmann-La Roche Ltd.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Illumina, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. PerkinElmer, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Bio-Rad Laboratories

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Thermo Fisher Scientific, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Agilent Technologies

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. GE Healthcare

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Promega Corp.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms